<SEC-DOCUMENT>0001213900-17-009915.txt : 20170922
<SEC-HEADER>0001213900-17-009915.hdr.sgml : 20170922
<ACCEPTANCE-DATETIME>20170922150748
ACCESSION NUMBER:		0001213900-17-009915
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170711
FILED AS OF DATE:		20170922
DATE AS OF CHANGE:		20170922

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Wolfe Robert
		CENTRAL INDEX KEY:			0001600148

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54478
		FILM NUMBER:		171097485

	MAIL ADDRESS:	
		STREET 1:		PO BOX 189
		CITY:			RANDOLPH
		STATE:			VT
		ZIP:			05060

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DanDrit Biotech USA, Inc.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		STUMPEDYSSEVEJ 17, 2970
		CITY:			H?RSHOLM
		STATE:			G7
		ZIP:			0
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		STUMPEDYSSEVEJ 17, 2970
		CITY:			H?RSHOLM
		STATE:			G7
		ZIP:			0

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Putnam Hills Corp.
		DATE OF NAME CHANGE:	20110810
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>f3071117wolfe_dandrit.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2017-07-11</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001527728</issuerCik>
        <issuerName>DanDrit Biotech USA, Inc.</issuerName>
        <issuerTradingSymbol>DDRT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001600148</rptOwnerCik>
            <rptOwnerName>Wolfe Robert</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DANDRIT BIOTECH USA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>P.O. BOX 189</rptOwnerStreet2>
            <rptOwnerCity>RANDOLPH</rptOwnerCity>
            <rptOwnerState>VT</rptOwnerState>
            <rptOwnerZipCode>05060</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer (1)</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>(1) Mr. Wolfe was appointed to serve as the Chief Financial Officer of DanDrit Biotech USA, Inc. on July 11, 2017.</remarks>

    <ownerSignature>
        <signatureName>/s/ Robert Wolfe</signatureName>
        <signatureDate>2017-09-22</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
